INTERVIEW: Vexim confident of breaking even by year-end
This article was originally published in Clinica
Executive Summary
French spinal technology firm Vexim has seen good growth since it went public in 2012, and is expecting to break even by the end of 2015. CEO Vincent Gardès spoke to Clinica soon after the company reported 69% sales expansion in 2014, to €10.3m ($11.4m).